John W Hollis Recalls Polidocanol 1% Solution Due to Incorrect Expiration Date
John W Hollis Inc is recalling 2 vials of Polidocanol 1% Solution because the expiration date on the vial is earlier than the date listed on the label.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences. The hazard is a minor labeling error regarding the expiration date.
Plain-English summary
John W Hollis Inc is recalling 2 vials of Polidocanol 1% Solution, 50 mL Vial, Rx Only, Not for Resale. The product was distributed in Missouri, Tennessee, Mississippi, and Wisconsin. The specific lot number is 565:27, and the expiration date is 5/31/14.
The recall was initiated due to a labeling error where the expiration date is earlier than the date listed on the vial. This discrepancy could lead to the use of expired medication.
Consumers who have this product should stop using it and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Polidocanol 1% Solution, 50 mL Vial, Rx Only, Not for Resale. John Hollis Pharmacy, 110 20th Avenue N, Nashville, TN 37203.
- Manufacturer
- John W Hollis Inc
- Category
- Drug — Pharmacy Compounded
- Hazard
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 565:27
- Expiry: 5/31/14
Distribution
Part of a larger recall action
This product is one of 4 recalled by John W Hollis Inc under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · John W Hollis Inc
See all →- SevereJohn W Hollis Inc Recalls Liver Derivative Complex Injection for Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Methylcobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Cyanocobalamin Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Compounded Injectable Products Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Recalls Polidocanol Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- ModerateHalyard Laparoscopy Comprehensive Pack II Recalled for Latex Content
FDA (Devices) · 2026-10-14
Similar recalls
- SevereJohn W Hollis Recalls Polidocanol 1% Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Recalls Polidocanol Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Recalls Polidocanol 5% Injection Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Pyridoxine HCl Injectable Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SevereJohn W Hollis Inc Recalls Compounded Injectable Products Due to Sterility Concerns
FDA (Drugs) · 2014-06-25
- SeverePolidocanol Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23